These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9533472)

  • 1. Sensitization of Burkholderia cepacia to antibiotics by cationic drugs.
    Rajyaguru JM; Muszynski MJ
    J Antimicrob Chemother; 1998 Feb; 41(2):277-80. PubMed ID: 9533472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of Burkholderia cepacia antimicrobial susceptibility by cationic compounds.
    Rajyaguru JM; Muszynski MJ
    J Antimicrob Chemother; 1997 Sep; 40(3):345-51. PubMed ID: 9338485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.
    Liu JY; Wang FD; Ho MW; Lee CH; Liu JW; Wang JT; Sheng WH; Hseuh PR; Chang SC
    J Microbiol Immunol Infect; 2016 Dec; 49(6):918-923. PubMed ID: 26364729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of antimicrobial agents, alone and in combinations, against Burkholderia cepacia isolated from blood.
    Lu DC; Chang SC; Chen YC; Luh KT; Hsieh WC
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):187-91. PubMed ID: 9327247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outer membrane vesicles produced by
    Kim SY; Kim MH; Son JH; Kim SI; Yun SH; Kim K; Kim S; Shin M; Lee JC
    Virulence; 2020 Dec; 11(1):995-1005. PubMed ID: 32799627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia.
    Aaron SD; Ferris W; Henry DA; Speert DP; Macdonald NE
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1206-12. PubMed ID: 10764313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted amines synergistic with tobramycin against Burkholderia cepacia in vitro.
    Cohn RC; Rudzienski L
    Chemotherapy; 1997; 43(2):100-7. PubMed ID: 9084918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gentamicin delivery to Burkholderia cepacia group IIIa strains via membrane vesicles from Pseudomonas aeruginosa PAO1.
    Allan ND; Beveridge TJ
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2962-5. PubMed ID: 12937002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial properties of investigational, new, and commonly used antibiotics against isolates of Pseudomonas cepacia in Michigan.
    Bhakta DR; Leader I; Jacobson R; Robinson-Dunn B; Honicky RE; Kumar A
    Chemotherapy; 1992; 38(5):319-23. PubMed ID: 1283733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interspecies effects in a ceftazidime-treated mixed culture of Pseudomonas aeruginosa, Burkholderia cepacia and Staphylococcus aureus: analysis at the single-species level.
    Riedele C; Reichl U
    J Antimicrob Chemother; 2011 Jan; 66(1):138-45. PubMed ID: 21062793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of azithromycin in combination with amikacin, ceftazidime, ciprofloxacin or imipenem against clinical isolates of Acinobacter baumannii.
    Fernández-Cuenca F; Martínez-Martínez L; Pascual A; Perea EJ
    Chemotherapy; 2003 May; 49(1-2):24-6. PubMed ID: 12714805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolates.
    Livermore DM; Mushtaq S; Ge Y; Warner M
    Int J Antimicrob Agents; 2009 Nov; 34(5):402-6. PubMed ID: 19428220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis.
    Manno G; Ugolotti E; Belli ML; Fenu ML; Romano L; Cruciani M
    Eur J Clin Microbiol Infect Dis; 2003 Jan; 22(1):28-34. PubMed ID: 12582741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia.
    Halwani M; Mugabe C; Azghani AO; Lafrenie RM; Kumar A; Omri A
    J Antimicrob Chemother; 2007 Oct; 60(4):760-9. PubMed ID: 17673475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of resistance to trimethoprim/sulphamethoxazole, chloramphenicol and quinolones with changes in major outer membrane proteins and lipopolysaccharide in Burkholderia cepacia.
    Rajyaguru JM; Muszynski MJ
    J Antimicrob Chemother; 1997 Dec; 40(6):803-9. PubMed ID: 9462431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
    Yasmin F; Akhtar N; Hameed A
    Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Burkholderia vietnamiensis to aminoglycosides.
    Jassem AN; Zlosnik JE; Henry DA; Hancock RE; Ernst RK; Speert DP
    Antimicrob Agents Chemother; 2011 May; 55(5):2256-64. PubMed ID: 21321142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients.
    Papp-Wallace KM; Becka SA; Zeiser ET; Ohuchi N; Mojica MF; Gatta JA; Falleni M; Tosi D; Borghi E; Winkler ML; Wilson BM; LiPuma JJ; Nukaga M; Bonomo RA
    ACS Infect Dis; 2017 Jul; 3(7):502-511. PubMed ID: 28264560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients.
    Traczewski MM; Brown SD
    Antimicrob Agents Chemother; 2006 Feb; 50(2):819-21. PubMed ID: 16436756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.